Souad Benaich
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Souad Benaich has a total of 93 co-authors. Here are the top co-authors by number of shared publications:
- Hassan Aguenaou
International University of Rabat
8 shared publications - Slimane Mehdad
Physiology and Physiopathology Research Team, Faculty of Sciences, Mohammed V University in Rabat, Morocco
7 shared publications - Aichetou Bouh
Mohammed V University in Rabat
5 shared publications - Daoud Daoudi
Mohammed V University in Rabat
5 shared publications - Amina Barkat
Department of Pediatrics (Neonatology), CHU Ibn Sina, Rabat 10000, Morocco
4 shared publications - Habiba Bajit
Team of Biochemistry of Natural Resources, Faculty of Sciences and Techniques, Moulay Ismaïl University, Errachidia, Morocco; Department of Pharmacology, Faculty of Medicine, University of Granada, Spain
4 shared publications
Latest Publications
- Open Access
- 1 July 2026
- Published by The North African Journal of Food and Nutrition Research (NAJFNR) in The North African Journal of Food and Nutrition Research
- Vol. 10 (22) , 15-27
Household Knowledge of Iodized Salt and Iodine Content of Dietary Salt in Morocco Further 25 Years of Universal Salt Iodization: A National Cross-Sectional Study
Background: At the global level, iodine deficiency (ID) has been significantly reduced since the widespread implementation of salt iodization programs; nevertheless, numerous populations worldwide remain at risk of insufficient iodine intake. In Morocco, the Universal Salt Iodization (USI) strategy was formally adopted in 1995 as a national public health measure to address this nutritional challenge. However, to date, no comprehensive national study has been conducted to evaluate the impact of this strategy on iodine adequacy at the household level. Aims: This cross-sectional study aims to assess the iodine content of dietary salts at the household level in Morocco on a national scale. Methods: A national cross-sectional study was conducted in 2019 among Moroccan households (n = 1963). Dietary salt samples were systematically collected from surveyed households to estimate household coverage of adequately iodized salt and to evaluate consumer awareness of iodization labelling. Iodine content analysis was performed employing the standardized iodometric titration method. Results: At the national level, the majority of households predominantly consumed packaged salt (89%), whilst bulk salt accounted for only 8.1% of total consumption. Packaged salt was significantly more prevalent in urban areas (93.3%), whereas bulk salt was more frequently consumed in rural areas (14%) (p < 0.05). Consistently, the majority of surveyed households (71%) were unaware of the "iodized salt" designation on product labelling. The median iodine content of salt samples collected from the 1,963 households was 7.40 ppm (CI: 7.4–8.0), indicating that only 7.5% (95% CI: 6.4–8.7) of the surveyed population consumed adequately iodized salt (15 – 40 ppm). Furthermore, 65.6% (95% CI: 63.5–67.7) consumed inadequately iodized salt (5–14.9 ppm); 25.7% (95% CI: 23.8–27.6) consumed non-iodized salt (< 5 ppm); and 1.2% (95% CI: 0.8–1.8) consumed over-iodized salt (> 40 ppm). Conclusion: Household coverage of adequately iodized salt remains critically low in Morocco, 25 years following the adoption of the USI strategy, underscoring the limited effectiveness of current program implementation. These findings highlight the urgent to reinforce and comprehensively revise the national salt iodization strategy through enhanced regulatory oversight, strengthened supply chain monitoring, improved consumer awareness campaigns, and targeted interventions in rural and nutritionally vulnerable populations, in order to fulfil the public health objectives of sustainable iodine deficiency elimination. Keywords: Iodine Deficiency; Salt Iodization; Morocco; Iodometric Titration; Public Health Nutrition.
- 1 July 2026
- Published by The North African Journal of Food and Nutrition Research (NAJFNR) in The North African Journal of Food and Nutrition Research
- Vol. 10 (22) , 15-27
Open AccessHousehold Knowledge of Iodized Salt and Iodine Content of Dietary Salt in Morocco Further 25 Years of Universal Salt Iodization: A National Cross-Sectional Study
Background: At the global level, iodine deficiency (ID) has been significantly reduced since the widespread implementation of salt iodization programs; nevertheless, numerous populations worldwide remain at risk of insufficient iodine intake. In Morocco, the Universal Salt Iodization (USI) strategy was formally adopted in 1995 as a national public health measure to address this nutritional challenge. However, to date, no comprehensive national study has been conducted to evaluate the impact of this strategy on iodine adequacy at the household level. Aims: This cross-sectional study aims to assess the iodine content of dietary salts at the household level in Morocco on a national scale. Methods: A national cross-sectional study was conducted in 2019 among Moroccan households (n = 1963). Dietary salt samples were systematically collected from surveyed households to estimate household coverage of adequately iodized salt and to evaluate consumer awareness of iodization labelling. Iodine content analysis was performed employing the standardized iodometric titration method. Results: At the national level, the majority of households predominantly consumed packaged salt (89%), whilst bulk salt accounted for only 8.1% of total consumption. Packaged salt was significantly more prevalent in urban areas (93.3%), whereas bulk salt was more frequently consumed in rural areas (14%) (p < 0.05). Consistently, the majority of surveyed households (71%) were unaware of the "iodized salt" designation on product labelling. The median iodine content of salt samples collected from the 1,963 households was 7.40 ppm (CI: 7.4–8.0), indicating that only 7.5% (95% CI: 6.4–8.7) of the surveyed population consumed adequately iodized salt (15 – 40 ppm). Furthermore, 65.6% (95% CI: 63.5–67.7) consumed inadequately iodized salt (5–14.9 ppm); 25.7% (95% CI: 23.8–27.6) consumed non-iodized salt (< 5 ppm); and 1.2% (95% CI: 0.8–1.8) consumed over-iodized salt (> 40 ppm). Conclusion: Household coverage of adequately iodized salt remains critically low in Morocco, 25 years following the adoption of the USI strategy, underscoring the limited effectiveness of current program implementation. These findings highlight the urgent to reinforce and comprehensively revise the national salt iodization strategy through enhanced regulatory oversight, strengthened supply chain monitoring, improved consumer awareness campaigns, and targeted interventions in rural and nutritionally vulnerable populations, in order to fulfil the public health objectives of sustainable iodine deficiency elimination. Keywords: Iodine Deficiency; Salt Iodization; Morocco; Iodometric Titration; Public Health Nutrition.
- Open Access
- 27 June 2026
- Published by Society of Land Measurements and Cadastre from Transylvania in Notulae Scientia Biologicae
- Vol. 18 (2)
Moroccan Cannabis sativa L. seed chloroform extract: phytochemistry, acute toxicity, and metabolic-behavioral effects in mice
Despite growing interest in the therapeutic use of Cannabis sativa L. following its legalization for medicinal purposes in 2021, the toxicity profile of its seeds remains largely underexplored in Morocco. This study aimed to characterize the phytochemical profile and acute oral toxicity of a chloroform seed extract (C/S) from Moroccan Cannabis sativa L. C/S extract (yield: 4.27 ± 0.13%) was analyzed by gas chromatography coupled with mass spectrometry (GC-MS). Acute toxicity testing was performed according to OECD Test Guideline 425: female Swiss mice (n = 5/group) received a single 2,000 mg kg⁻¹ oral dose or vehicle control, followed by 14 d monitoring of clinical signs, body weight (BW), organ weight, and serum biochemistry (ASAT/ALAT, creatinine, urea, and lipid profile). GC-MS analysis revealed 16 compounds, with octacosane (6.80%), 2-methyloctadecane (5.75%), and cannabidiol (5.32%) as the major components. No treatment-related mortality was observed (LD₅₀ > 2,000 mg kg⁻¹), and only transient signs of hypoactivity/tachycardia were noted, which resolved spontaneously within a few hours. BW gain (p = 0.154), liver/BW (p = 0.103), and kidney/BW (p = 0.406) ratios showed no significant differences. Total cholesterol was lower in the C/S group than in controls (0.82 ± 0.06 g L⁻¹ vs. 2.13 ± 0.38 g L⁻¹, p = 0.014), whereas LDL-C was higher in the C/S group (0.07 ± 0.00 g L⁻¹ vs. 0.03 ± 0.01 g L⁻¹, p = 0.002). The C/S extract demonstrated low acute toxicity under the tested conditions, supporting further safety-oriented pharmaceutical investigation of Moroccan Cannabis sativa L. seeds.
- 27 June 2026
- Published by Society of Land Measurements and Cadastre from Transylvania in Notulae Scientia Biologicae
- Vol. 18 (2)
Open AccessMoroccan Cannabis sativa L. seed chloroform extract: phytochemistry, acute toxicity, and metabolic-behavioral effects in mice
Despite growing interest in the therapeutic use of Cannabis sativa L. following its legalization for medicinal purposes in 2021, the toxicity profile of its seeds remains largely underexplored in Morocco. This study aimed to characterize the phytochemical profile and acute oral toxicity of a chloroform seed extract (C/S) from Moroccan Cannabis sativa L. C/S extract (yield: 4.27 ± 0.13%) was analyzed by gas chromatography coupled with mass spectrometry (GC-MS). Acute toxicity testing was performed according to OECD Test Guideline 425: female Swiss mice (n = 5/group) received a single 2,000 mg kg⁻¹ oral dose or vehicle control, followed by 14 d monitoring of clinical signs, body weight (BW), organ weight, and serum biochemistry (ASAT/ALAT, creatinine, urea, and lipid profile). GC-MS analysis revealed 16 compounds, with octacosane (6.80%), 2-methyloctadecane (5.75%), and cannabidiol (5.32%) as the major components. No treatment-related mortality was observed (LD₅₀ > 2,000 mg kg⁻¹), and only transient signs of hypoactivity/tachycardia were noted, which resolved spontaneously within a few hours. BW gain (p = 0.154), liver/BW (p = 0.103), and kidney/BW (p = 0.406) ratios showed no significant differences. Total cholesterol was lower in the C/S group than in controls (0.82 ± 0.06 g L⁻¹ vs. 2.13 ± 0.38 g L⁻¹, p = 0.014), whereas LDL-C was higher in the C/S group (0.07 ± 0.00 g L⁻¹ vs. 0.03 ± 0.01 g L⁻¹, p = 0.002). The C/S extract demonstrated low acute toxicity under the tested conditions, supporting further safety-oriented pharmaceutical investigation of Moroccan Cannabis sativa L. seeds.
- Open Access
- 12 February 2026
- Published by Elsevier in Clinical Epidemiology and Global Health
- Vol. 38
Prevalence and correlates of metabolic syndrome in type 2 diabetes patients: A cross sectional study at the provincial diabetes center in Meknes, Morocco
- 12 February 2026
- Published by Elsevier in Clinical Epidemiology and Global Health
- Vol. 38
Open AccessPrevalence and correlates of metabolic syndrome in type 2 diabetes patients: A cross sectional study at the provincial diabetes center in Meknes, Morocco
- Open Access
- 12 December 2025
- Published by The North African Journal of Food and Nutrition Research (NAJFNR) in The North African Journal of Food and Nutrition Research
Nutritional Status, Muscle Mass, and Body Fat Percentage in Patients with Breast Cancer Undergoing Adjuvant Chemotherapy
Aims: To evaluate alterations in weight, body composition, and nutritional parameters, and to identify the clinical, anthropometric, and dietary determinants of these changes among patients with breast cancer (BC) treated with adjuvant chemotherapy (AC). Methods: This study involved a cohort of 252 BC patients treated with AC. Anthropometric measurements were collected using standardized equipment and body composition was evaluated via bioelectrical impedance analysis (BIA). Clinical data were retrieved from the hospital's information system. Adherence to the Mediterranean Diet (MedDiet) was evaluated using a validated food frequency questionnaire. Results: Post-AC, 29.3% and 22.7% of patients experienced moderate/high weight gain (WG ≥ 5%) and moderate/severe weight loss (MSWL ≥ 5%), respectively. The prevalence of patients with low muscle mass (LMM) and sarcopenic obesity increased from 11.5% and 2.8% pre-treatment to 15.1% and 7.9% post-treatment, respectively. Younger women (aged 24 – 39 years) exhibited reduced odds of experiencing MSWL (OR = 0.31, 95%CI: 0.08 – 1.20) and LMM (OR = 0.19, 95%CI: 0.02 – 1.61) compared to those aged ≥ 60 years. Patients with BC stages I and II were associated with increased odds of WG (OR = 2.10, 95%CI: 0.44 – 9.89; and OR = 2.13, 95%CI: 0.46 – 9.68, respectively). Relative to obese individuals, normal-weight/underweight individuals exhibited a significantly higher likelihood of WG (OR = 2.29; 95%CI: 1.03 – 5.08) and MSWL (OR = 3.23, 95%CI: 1.19 – 8.80), but a lower likelihood of LMM (OR = 0.33, 95%CI: 0.13 – 0.87). The Anthracycline-Taxane and Monoclonal-antibodies-Taxane regimens were associated with higher odds of MSWL (OR = 3.64, 95%CI: 0.35 – 36.98, and OR = 2.63, 95%CI: 1.03 – 6.72, respectively). Low and moderate adherence to the MedDiet were independently associated with an elevated risk of both WG and MSWL. Conclusions: A substantial proportion of patients with BC experience significant weight fluctuation or deterioration in muscle mass following AC. These adverse outcomes are modulated by patient age, cancer stage or duration, baseline BMI, the specific chemotherapy regimen employed, and MeDiet adherence. Keywords: Adjuvant chemotherapy; Body composition; Body Mass Index; Breast cancer; Mediterranean diet; Weight change.
- 12 December 2025
- Published by The North African Journal of Food and Nutrition Research (NAJFNR) in The North African Journal of Food and Nutrition Research
Open AccessNutritional Status, Muscle Mass, and Body Fat Percentage in Patients with Breast Cancer Undergoing Adjuvant Chemotherapy
Aims: To evaluate alterations in weight, body composition, and nutritional parameters, and to identify the clinical, anthropometric, and dietary determinants of these changes among patients with breast cancer (BC) treated with adjuvant chemotherapy (AC). Methods: This study involved a cohort of 252 BC patients treated with AC. Anthropometric measurements were collected using standardized equipment and body composition was evaluated via bioelectrical impedance analysis (BIA). Clinical data were retrieved from the hospital's information system. Adherence to the Mediterranean Diet (MedDiet) was evaluated using a validated food frequency questionnaire. Results: Post-AC, 29.3% and 22.7% of patients experienced moderate/high weight gain (WG ≥ 5%) and moderate/severe weight loss (MSWL ≥ 5%), respectively. The prevalence of patients with low muscle mass (LMM) and sarcopenic obesity increased from 11.5% and 2.8% pre-treatment to 15.1% and 7.9% post-treatment, respectively. Younger women (aged 24 – 39 years) exhibited reduced odds of experiencing MSWL (OR = 0.31, 95%CI: 0.08 – 1.20) and LMM (OR = 0.19, 95%CI: 0.02 – 1.61) compared to those aged ≥ 60 years. Patients with BC stages I and II were associated with increased odds of WG (OR = 2.10, 95%CI: 0.44 – 9.89; and OR = 2.13, 95%CI: 0.46 – 9.68, respectively). Relative to obese individuals, normal-weight/underweight individuals exhibited a significantly higher likelihood of WG (OR = 2.29; 95%CI: 1.03 – 5.08) and MSWL (OR = 3.23, 95%CI: 1.19 – 8.80), but a lower likelihood of LMM (OR = 0.33, 95%CI: 0.13 – 0.87). The Anthracycline-Taxane and Monoclonal-antibodies-Taxane regimens were associated with higher odds of MSWL (OR = 3.64, 95%CI: 0.35 – 36.98, and OR = 2.63, 95%CI: 1.03 – 6.72, respectively). Low and moderate adherence to the MedDiet were independently associated with an elevated risk of both WG and MSWL. Conclusions: A substantial proportion of patients with BC experience significant weight fluctuation or deterioration in muscle mass following AC. These adverse outcomes are modulated by patient age, cancer stage or duration, baseline BMI, the specific chemotherapy regimen employed, and MeDiet adherence. Keywords: Adjuvant chemotherapy; Body composition; Body Mass Index; Breast cancer; Mediterranean diet; Weight change.
- Open Access
- 11 November 2025
- Published by Society of Land Measurements and Cadastre from Transylvania in Notulae Scientia Biologicae
- Vol. 17 (4)
Comparative study of the phytochemical profile, antioxidant, and cytotoxicity activities of different co-product extracts of Cannabis sativa L. leaves
Cannabis sativa L. is one of the most extensively studied medicinal plants due to its wide array of bioactive metabolites with therapeutic and industrial applications. In this study, leaf co-products were valorized by assessing their phytochemical composition, antioxidant potential, and cytotoxic activity using three extraction techniques: decoction, sonication, and maceration. The decoction method produced the highest extraction yield, while sonication resulted in extracts with the greatest concentrations of total phenolics (43.2 mg GAE/g) and flavonoids (24.09 mg QE/g). Gas Chromatography–Mass Spectrometry (GC–MS) analysis revealed distinct chemical signatures for each extract, confirming the strong influence of the extraction process on metabolite recovery. Antioxidant evaluation showed that the sonication extract exhibited the most pronounced free radical scavenging effect (DPPH assay, IC₅₀ = 36.95 µg/mL), whereas the maceration extract exhibited the highest reducing power in the FRAP assay (97%). Cytotoxicity assays conducted on Vero (normal kidney) and HT-29 (human colorectal cancer) cell lines demonstrated inhibitory effects for all extracts, with the sonication extract showing the strongest activity against HT-29 cells. A significant association of the sonication extract between its antioxidant potential and cytotoxic properties was observed. Overall, these findings highlight Cannabis sativa leaf co-products as promising sources of bioactive compounds with potential applications in both pharmaceutical and nutraceutical development.
- 11 November 2025
- Published by Society of Land Measurements and Cadastre from Transylvania in Notulae Scientia Biologicae
- Vol. 17 (4)
Open AccessComparative study of the phytochemical profile, antioxidant, and cytotoxicity activities of different co-product extracts of Cannabis sativa L. leaves
Cannabis sativa L. is one of the most extensively studied medicinal plants due to its wide array of bioactive metabolites with therapeutic and industrial applications. In this study, leaf co-products were valorized by assessing their phytochemical composition, antioxidant potential, and cytotoxic activity using three extraction techniques: decoction, sonication, and maceration. The decoction method produced the highest extraction yield, while sonication resulted in extracts with the greatest concentrations of total phenolics (43.2 mg GAE/g) and flavonoids (24.09 mg QE/g). Gas Chromatography–Mass Spectrometry (GC–MS) analysis revealed distinct chemical signatures for each extract, confirming the strong influence of the extraction process on metabolite recovery. Antioxidant evaluation showed that the sonication extract exhibited the most pronounced free radical scavenging effect (DPPH assay, IC₅₀ = 36.95 µg/mL), whereas the maceration extract exhibited the highest reducing power in the FRAP assay (97%). Cytotoxicity assays conducted on Vero (normal kidney) and HT-29 (human colorectal cancer) cell lines demonstrated inhibitory effects for all extracts, with the sonication extract showing the strongest activity against HT-29 cells. A significant association of the sonication extract between its antioxidant potential and cytotoxic properties was observed. Overall, these findings highlight Cannabis sativa leaf co-products as promising sources of bioactive compounds with potential applications in both pharmaceutical and nutraceutical development.
- Open Access
- 26 June 2025
- Published by The North African Journal of Food and Nutrition Research (NAJFNR) in The North African Journal of Food and Nutrition Research
- Vol. 9 (20) , 310-322
Nutritional Status, Muscle Mass, and Body Fat Percentage in Patients with Breast Cancer Undergoing Adjuvant Chemotherapy
Aims: To evaluate alterations in weight, body composition, and nutritional parameters, and to identify the clinical, anthropometric, and dietary determinants of these changes among patients with breast cancer (BC) treated with adjuvant chemotherapy (AC). Methods: This study involved a cohort of 252 BC patients treated with AC. Anthropometric measurements were collected using standardized equipment and body composition was evaluated via bioelectrical impedance analysis (BIA). Clinical data were retrieved from the hospital's information system. Adherence to the Mediterranean Diet (MedDiet) was evaluated using a validated food frequency questionnaire. Results: Post-AC, 29.3% and 22.7% of patients experienced moderate/high weight gain (WG ≥ 5%) and moderate/severe weight loss (MSWL ≥ 5%), respectively. The prevalence of patients with low muscle mass (LMM) and sarcopenic obesity increased from 11.5% and 2.8% pre-treatment to 15.1% and 7.9% post-treatment, respectively. Younger women (aged 24 – 39 years) exhibited reduced odds of experiencing MSWL (OR = 0.31, 95%CI: 0.08 – 1.20) and LMM (OR = 0.19, 95%CI: 0.02 – 1.61) compared to those aged ≥ 60 years. Patients with BC stages I and II were associated with increased odds of WG (OR = 2.10, 95%CI: 0.44 – 9.89; and OR = 2.13, 95%CI: 0.46 – 9.68, respectively). Relative to obese individuals, normal-weight/underweight individuals exhibited a significantly higher likelihood of WG (OR = 2.29; 95%CI: 1.03 – 5.08) and MSWL (OR = 3.23, 95%CI: 1.19 – 8.80), but a lower likelihood of LMM (OR = 0.33, 95%CI: 0.13 – 0.87). The Anthracycline-Taxane and Monoclonal-antibodies-Taxane regimens were associated with higher odds of MSWL (OR = 3.64, 95%CI: 0.35 – 36.98, and OR = 2.63, 95%CI: 1.03 – 6.72, respectively). Low and moderate adherence to the MedDiet were independently associated with an elevated risk of both WG and MSWL. Conclusions: A substantial proportion of patients with BC experience significant weight fluctuation or deterioration in muscle mass following AC. These adverse outcomes are modulated by patient age, cancer stage or duration, baseline BMI, the specific chemotherapy regimen employed, and MeDiet adherence. Keywords: Adjuvant chemotherapy; Body composition; Body mass index; Breast cancer; Mediterranean diet; Weight change.
- 26 June 2025
- Published by The North African Journal of Food and Nutrition Research (NAJFNR) in The North African Journal of Food and Nutrition Research
- Vol. 9 (20) , 310-322
Open AccessNutritional Status, Muscle Mass, and Body Fat Percentage in Patients with Breast Cancer Undergoing Adjuvant Chemotherapy
Aims: To evaluate alterations in weight, body composition, and nutritional parameters, and to identify the clinical, anthropometric, and dietary determinants of these changes among patients with breast cancer (BC) treated with adjuvant chemotherapy (AC). Methods: This study involved a cohort of 252 BC patients treated with AC. Anthropometric measurements were collected using standardized equipment and body composition was evaluated via bioelectrical impedance analysis (BIA). Clinical data were retrieved from the hospital's information system. Adherence to the Mediterranean Diet (MedDiet) was evaluated using a validated food frequency questionnaire. Results: Post-AC, 29.3% and 22.7% of patients experienced moderate/high weight gain (WG ≥ 5%) and moderate/severe weight loss (MSWL ≥ 5%), respectively. The prevalence of patients with low muscle mass (LMM) and sarcopenic obesity increased from 11.5% and 2.8% pre-treatment to 15.1% and 7.9% post-treatment, respectively. Younger women (aged 24 – 39 years) exhibited reduced odds of experiencing MSWL (OR = 0.31, 95%CI: 0.08 – 1.20) and LMM (OR = 0.19, 95%CI: 0.02 – 1.61) compared to those aged ≥ 60 years. Patients with BC stages I and II were associated with increased odds of WG (OR = 2.10, 95%CI: 0.44 – 9.89; and OR = 2.13, 95%CI: 0.46 – 9.68, respectively). Relative to obese individuals, normal-weight/underweight individuals exhibited a significantly higher likelihood of WG (OR = 2.29; 95%CI: 1.03 – 5.08) and MSWL (OR = 3.23, 95%CI: 1.19 – 8.80), but a lower likelihood of LMM (OR = 0.33, 95%CI: 0.13 – 0.87). The Anthracycline-Taxane and Monoclonal-antibodies-Taxane regimens were associated with higher odds of MSWL (OR = 3.64, 95%CI: 0.35 – 36.98, and OR = 2.63, 95%CI: 1.03 – 6.72, respectively). Low and moderate adherence to the MedDiet were independently associated with an elevated risk of both WG and MSWL. Conclusions: A substantial proportion of patients with BC experience significant weight fluctuation or deterioration in muscle mass following AC. These adverse outcomes are modulated by patient age, cancer stage or duration, baseline BMI, the specific chemotherapy regimen employed, and MeDiet adherence. Keywords: Adjuvant chemotherapy; Body composition; Body mass index; Breast cancer; Mediterranean diet; Weight change.
- Open Access
- 10 May 2025
- Published by Elsevier in Clinical Epidemiology and Global Health
- Vol. 34
Exploring the relationships of Metabolic Syndrome with sociodemographic factors, weight status, dietary and lifestyle behaviors in Moroccan adults
- 10 May 2025
- Published by Elsevier in Clinical Epidemiology and Global Health
- Vol. 34
Open AccessExploring the relationships of Metabolic Syndrome with sociodemographic factors, weight status, dietary and lifestyle behaviors in Moroccan adults
- Open Access
- 28 February 2025
- Published by European Publishing in Population Medicine
- Vol. 7 (February) , 1-10
Investigating the association of tobacco smoking with obesity, hyperglycemia, high blood pressure, and dyslipidemia in Moroccan adults: Findings from a nationally representative cross-sectional survey
Introduction: There has been a reduction in tobacco smoking worldwide except in developing countries, where progress in addressing its harms has been slow. We aimed to estimate smoking prevalence and investigate its association with obesity, hyperglycemia, high blood pressure, and dyslipidemia...
- 28 February 2025
- Published by European Publishing in Population Medicine
- Vol. 7 (February) , 1-10
Open AccessInvestigating the association of tobacco smoking with obesity, hyperglycemia, high blood pressure, and dyslipidemia in Moroccan adults: Findings from a nationally representative cross-sectional survey
Introduction: There has been a reduction in tobacco smoking worldwide except in developing countries, where progress in addressing its harms has been slow. We aimed to estimate smoking prevalence and investigate its association with obesity, hyperglycemia, high blood pressure, and dyslipidemia...
- Open Access
- 1 January 2022
- Published by Pan African Medical Journal in Pan African Medical Journal
- Vol. 41 (156) , 156
Association between overweight and anemia in Moroccan adolescents: a cross-sectional study
INTRODUCTION: Obesity and anemia remain global public health problems, having major negative effects on human health. We aimed to estimate the prevalence of anemia and investigate its association with overweight/obesity and excess body fat among Moroccan adolescents. METHODS: A total of 292 adolescents aged 11-17 years were recruited. Body mass index (BMI) and waist circumference (WC) were determined using standardized equipment. Body fat mass was measured by bioelectrical impedance analysis. Hemoglobin concentration was measured by the HemoCue method. RESULTS: The overall prevalence of anemia was 13.7%. Anemia was more common among overweight/obese participants (15.2%) compared to non-overweight participants (12.8%). Overweight/obese boys were more likely to experience anemia than their non-overweight peers (odds ratio (OR): 1.49; 95% confidence interval (95%CI): 0.51-4.41). Similarly, anemia likelihood was higher among individuals having excess body fat than those who do not have excess body fat, particularly among girls (OR: 1.64; 95%CI: 0.69-3.87). Excess body fat was also significantly associated with lower hemoglobin concentration in both the total sample and girls (P=0.014, and P=0.041, respectively). Overall, increased BMI, WC, fat mass, and percent body fat were associated with reduced hemoglobin concentrations. There was a significant negative correlation between hemoglobin concentration and BMI among anemic girls (P=0.023). CONCLUSION: Elevated BMI and body fat level were associated with lower hemoglobin concentrations and anemia. Further studies are needed to delineate the basis of such associations, and if these findings are confirmed, the guidelines for screening for anemia may need to be modified to include overweight/obesity as a risk factor.
- 1 January 2022
- Published by Pan African Medical Journal in Pan African Medical Journal
- Vol. 41 (156) , 156
Open AccessAssociation between overweight and anemia in Moroccan adolescents: a cross-sectional study
INTRODUCTION: Obesity and anemia remain global public health problems, having major negative effects on human health. We aimed to estimate the prevalence of anemia and investigate its association with overweight/obesity and excess body fat among Moroccan adolescents. METHODS: A total of 292 adolescents aged 11-17 years were recruited. Body mass index (BMI) and waist circumference (WC) were determined using standardized equipment. Body fat mass was measured by bioelectrical impedance analysis. Hemoglobin concentration was measured by the HemoCue method. RESULTS: The overall prevalence of anemia was 13.7%. Anemia was more common among overweight/obese participants (15.2%) compared to non-overweight participants (12.8%). Overweight/obese boys were more likely to experience anemia than their non-overweight peers (odds ratio (OR): 1.49; 95% confidence interval (95%CI): 0.51-4.41). Similarly, anemia likelihood was higher among individuals having excess body fat than those who do not have excess body fat, particularly among girls (OR: 1.64; 95%CI: 0.69-3.87). Excess body fat was also significantly associated with lower hemoglobin concentration in both the total sample and girls (P=0.014, and P=0.041, respectively). Overall, increased BMI, WC, fat mass, and percent body fat were associated with reduced hemoglobin concentrations. There was a significant negative correlation between hemoglobin concentration and BMI among anemic girls (P=0.023). CONCLUSION: Elevated BMI and body fat level were associated with lower hemoglobin concentrations and anemia. Further studies are needed to delineate the basis of such associations, and if these findings are confirmed, the guidelines for screening for anemia may need to be modified to include overweight/obesity as a risk factor.